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Abstract
Background: Postpartum Haemorrhage (PPH) is a leading cause of maternal mortality with approximately 225
women dying as a result of it each day especially in low income countries. However, much less is known about
morbidity after a PPH. This systematic review aimed to determine the overall prevalence of emotional and physical
health problems experienced by women following a postpartum haemorrhage.
Methods: Eight databases were searched for published non-randomised, observational, including cohort, primary
research studies that reported on the prevalence of emotional and/or physical health problems following a PPH.
Intervention studies were included and data, if available, were abstracted on the control group. All authors
independently screened the papers for inclusion. Of the 2210 papers retrieved, six met the inclusion criteria.
Data were extracted independently by two authors. The methodological quality of the included studies was
assessed using a modified Newcastle Ottawa Scale (NOS). The primary outcome measure reported was
emotional and physical health problems up to 12 months postpartum following a postpartum haemorrhage.
Results: Two thousand two hundred ten citations were identified and screened with 2089 excluded by title
and abstract. Following full-text review of 121 papers, 115 were excluded. The remaining 6 studies were
included. All included studies were judged as having strong or moderate methodological quality. Five studies
had the sequelae of PPH as their primary focus, and one study focused on morbidity postnatally, from which
we could extract data on PPH. Persistent morbidities following PPH (at ≥ 3 and < 6 months postpartum) included
postnatal depression (13 %), post-traumatic stress disorder (3 %), and health status ‘much worse than one year ago’
(6 %). Due to the different types of health outcomes reported in the individual studies, it was possible to pool results
from only four studies, and only then by accepting the slightly differing definitions of PPH. Those that could be pooled
reported rates of acute renal failure (0.33 %), coagulopathy (1.74 %) and re-admission to hospital following a PPH
between 1 and 3 months postpartum (3.6 %), an appreciable indication of underlying physical problems.
Conclusion: This systematic review demonstrates that the existence and type of physical and emotional health
problems post PPH, regardless of the volume of blood lost, are largely unknown. Further large cohort or case control
studies are necessary to obtain better knowledge of the sequelae of this debilitating morbidity.
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Background
Postpartum Haemorrhage (PPH) is recognised as one of
the leading causes of maternal mortality worldwide, ac-
counting for 1 in 4 maternal deaths globally, but much
less is known about morbidity post PPH. At least 225
women die from PPH every day, the majority of these
deaths occurring in low income countries [1]. In the
most recent Confidential Enquiries into Maternal Deaths
(2011–13) in the UK, PPH was identified as being re-
sponsible for 10 % of direct maternal deaths [2]. Histor-
ically, maternal mortality has been used as an indicator
of the quality of maternity services; however, as women’s
general health improves, and preventative care and treat-
ment for PPH become more accessible, more women are
surviving PPH, making the evaluation of morbidity a
useful complementary measure.
Although PPH is itself a maternal morbidity, the out-
comes for women who experience a PPH have not been
studied widely. A surveillance study conducted in 27 ob-
stetric units in Brazil found the maternal near miss ratio
to be 2.2 per 1000 women with PPH [3]. Wagner et el.
[4] describe a review of 11 studies, showing that PPH re-
sulted in anaemia with a summary ratio of 2.35 (95 % CI
1.44–3.84), albeit with considerable heterogeneity. Emo-
tional outcomes occur also, with the majority of women
who experience PPH having negative memories of the
birth including, for some, a persistent fear of dying [5].
A systematic review of women’s experiences of all types
of severe maternal morbidity showed that women found
these incidents physically and emotionally distressing
[6], and therefore worthy of study.
The prevalence of PPH varies, with the worldwide
prevalence thought to be between 6 and 11 % [7]. In
England, the incidence increased from 7 % in 2004/5 to
13 % in 2011/12 [8]. In an eleven-year population-based
cohort study in Ireland, the rate of PPH increased from
1.5 % in 1999 to 4.1 % in 2009 [9]. In Australia (NSW),
the PPH rate increased from 6.1 % in 2003 to 8.3 % in
2011 [10].
More recently, the rate in one large Dublin maternity
hospital was 14.6 % in 2014, a 4-fold increase from the
3.3 % incidence reported in 2008 [11]. Whilst some of
these increases may be a result of more accurate estima-
tion of blood loss, or because PPH was redefined with a
lower threshold of blood loss, it never-the-less means
that more women are experiencing PPH.
Given the prevalence of PPH and approximately 135
million births occurring worldwide each year, approxi-
mately 8–11 million women will experience a PPH and
many will suffer some health sequelae. The focus of this
systematic review, therefore, was on determining the
overall prevalence of emotional and physical health
problems experienced by women following a postpartum
haemorrhage.
Defining postpartum haemorrhage
PPH is defined in four different ways by WHO [1], RCOG
[12], ICD-10 codes [13] and NICE [14]. Primary (some-
times referred to as immediate or early) occurs within 24 h
of birth, whilst secondary (sometimes referred to as delayed
or late) occurs after 24 h and up to 12 weeks postpartum.
In these four definitions, the common component is the
inclusion of blood loss greater than 500 mls for a primary
PPH. For secondary PPH, only the ICD-10 codes [13] cat-
egorise blood loss as being greater than 500 mls. The terms
used in two other definitions state ‘abnormal or excessive
bleeding from the birth canal’ [12] / or ‘of the amount that
adversely affects the maternal physiology’ [13]. WHO [1] or
NICE [14] do not define secondary PPH.
Other terms used to define PPH include major obstet-
ric haemorrhage, defined not only according to blood
loss (>2500 mls), but also by number of transfused units
of blood (n = 5) or requiring coagulopathy treatment
(e.g., fresh frozen plasma, fibrinogen concentrate substi-
tution therapy, platelets) [15, 16].
However, despite the definition used, being able to es-
timate blood loss accurately is recognised as being al-
most clinically impossible [17], and studies have shown
that blood loss is overestimated at low volumes and
underestimated when the volume is large thus underesti-
mating the severity of the PPH [18–20].
Defining maternal morbidity - women’s physical and
emotional health problems
The term ‘maternal morbidity’ encompasses a wide range
of acute and chronic conditions, ranging from ‘near death’
or ‘near miss’ to non-life threatening events. A WHO re-
view, undertaken to create a consensus around a definition
of maternal morbidity, found significant discrepancies in
the literature and amongst experts [21]. More recently,
population based studies have reported prevalence of
severe maternal morbidity and, according to these reports,
1 in 140 pregnant women will suffer from a severe mor-
bidity, the most common being PPH [16]. In Ireland,
major obstetric haemorrhage was also the most common
cause of severe maternal morbidity, with a rate of 2.55 per
1000 maternities [15]. These rates are for severe haemor-
rhage only, meaning that the prevalence of any degree of
PPH in the wider maternity population is much greater.
Methods
Aim and objectives
This systematic review aimed to determine the overall
prevalence of emotional and physical health problems
experienced by women following a postpartum haemor-
rhage. The objectives were:
To determine the prevalence of women’s emotional
health problems following a postpartum haemorrhage
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up to 3 months, >3 months and ≤6 months, and >6
months and ≤12 months postpartum; and
To determine the prevalence of women’s physical
health problems following a postpartum haemorrhage
up to 3 months, >3 months and ≤6 months, and >6
months and ≤12 months postpartum.
Outcomes
Primary outcome measures were the reported emotional
and physical health problems up to 12 months postpar-
tum following a postpartum haemorrhage. The type of
haemorrhage experienced included: 1. Primary / imme-
diate PPH; 2. Secondary / delayed PPH; and 3. PPH ac-
cording to definition (as defined by WHO [1], RCOG
[12], ICD-10 codes [13] and NICE [14]). When studies
did not cite any of the above references, their definition
was abstracted and assessed.
Secondary outcome measures were women’s physical
and/or emotional health problems following PPH accord-
ing to parity, age, BMI and mode of birth and amount of
blood lost/severity of PPH.
Inclusion and exclusion criteria
Inclusion and exclusion criteria were determined a
priori. Eligible participants were postpartum women, ir-
respective of parity, who had given birth to a baby of at
least 24 weeks gestation and who experienced a postpar-
tum haemorrhage. An individual study had to report pri-
mary data on prevalence of emotional and/or physical
health problems at any time point up to 12 months post-
partum, to be included.
Published non-randomised, observational including
cohort primary research studies, reporting on preva-
lence of emotional and/or physical health problems fol-
lowing a PPH were included. Intervention studies were
included and data, if available, were abstracted on the
control group.
Case reports, reviews and qualitative studies were
excluded.
Search and selection strategy
A computerised search of the following electronic data-
bases was performed from their foundation to April
2015: CINAHL , PubMED (MEDLINE not searched as
included in PubMED), Maternity and Infant Care, Psy-
cINFO, EMBASE (also includes deduplicated MEDLINE
citations from 1966 to the present), Web of Science,
Social Science Index and The Cochrane Library. Key
words, search terms and string were developed, tested
and adapted for each database. The search was not
restricted by year or English language publications.
Search terms were developed for the three key terms:
‘postpartum haemorrhage’, ‘postnatal period’ and
‘women’s emotional and physical health’ (Table 1).
Search strings for individual databases were created
(Additional file 1: Search Strings for Databases).
Following an initial scoping search, the search was
limited to ‘title’ OR ‘abstract’. The appropriate search
terms were combined with the Boolean operands ‘AND’
and ‘OR’ as appropriate.
Reference lists of papers retrieved for full text review
were also reviewed for potentially eligible papers that
may not have been captured by the electronic search
strategy [22].
Data management processes
The review followed the processes recommended by
Higgins and Green [23]. Following agreement on the
final search string, the selection of eligible studies and
data extraction were performed by three people inde-
pendently (MC, CB and DD), and the final results com-
pared, thus minimising the likelihood that errors would
go undetected. MC, CB and DD have expertise in mid-
wifery, CB has systematic review and statistical expertise,
DD has systematic review expertise.
Quality assessment of included studies
The Newcastle Ottawa Scale (NOS) [24] was modified
and a scale of 0–6 stars was used to assess methodo-
logical quality of included studies (Table 2). Six stars was
deemed as strong, four to five stars was deemed as mod-
erate and three or fewer stars was deemed as weak
methodological quality. Studies judged to have weak
methodological quality were excluded from the data ex-
traction process. All items were regarded as equally im-
portant, and no weighting was applied to any item or
category.
Data extraction management
The following data were abstracted and inserted in a
data collection form, designed a priori.
Primary outcome measures
i. Country of study, study design, date of data
collection, and methods used
ii. Definition of PPH, if any, used.
The number of women reported as having a PPH, and
who also reported a particular physical and/or emotional
health problem, and the postpartum time it was reported.
Data analysis
Where possible, data reported on similar outcomes at
the same time points were pooled.
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Results
Results of search and selection strategy
Following removal of duplicates, a total of 2210 pa-
pers were retrieved (Fig. 1), and 978 were excluded
on title screening. A further 1111 were excluded on
abstract screening, and the remaining 121 papers
were subjected to full text review. Citations not in
English were screened at this stage using Google
translate. A total of 12 papers appeared to meet the
inclusion criteria for this review [25–36]; however, at
data extraction stage it was realised that we were un-
able to abstract data from six papers [26, 29, 32–35]
because the outcomes reported in these papers all re-
lated to management or treatments of PPH, and no
maternal physical or emotional health outcomes were
reported.
Table 1 Key words and search terms and string
Key words Search terms/String
Postnatal period TI postnatal OR AB postnatal OR TI post natal OR AB post natal OR TI post-natal OR AB post-natal OR TI postpartum
OR AB postpartum OR TI post partum OR AB post partum OR TI post-partum OR AB post-partum OR TI “postnatal
period” OR AB “postnatal period” OR TI “post natal period” OR AB “post natal period” OR TI “post-natal period” OR
AB “post-natal period” OR TI “postpartum period” OR AB “postpartum period” OR TI “post partum period” OR AB
“post partum period” OR TI “post-partum period” OR AB “post-partum period” OR TI puerperium OR AB Puerperium
OR TI peripartum OR AB peripartum OR TI peri partum OR AB peri partum OR TI peri-partum OR AB peri-partum OR
TI “peripartum period” OR AB “peripartum period” OR TI “peri partum period” OR AB “peri partum period” OR TI
“peri-partum period” OR AB “peri-partum period” OR TI peripartum period OR AB peripartum period
Postpartum haemorrhage TI PPH OR AB PPH OR TI postpartum haemorrhage OR AB postpartum haemorrhage OR TI post partum haemorrhage
OR AB post partum haemorrhage OR TI post-partum haemorrhage OR AB post-partum haemorrhage OR TI postpartum
hemorrhage OR AB postpartum hemorrhage OR TI post partum hemorrhage OR AB post partum hemorrhage OR TI
post-partum hemorrhage OR AB post-partum hemorrhage OR TI obstetric haemorrhage OR AB obstetric haemorrhage
OR TI obstetric hemorrhage OR AB obstetric hemorrhage OR TI major obstetric haemorrhage OR AB major obstetric
haemorrhage OR TI major obstetric hemorrhage OR AB major obstetric hemorrhage OR TI massive haemorrhage OR AB
massive haemorrhage OR TI massive hemorrhage OR AB massive hemorrhage OR TI massive obstetric haemorrhage OR
AB massive obstetric haemorrhage OR TI massive obstetric hemorrhage OR AB massive obstetric hemorrhage OR TI
severe haemorrhage OR AB severe haemorrhage OR TI severe hemorrhage OR AB severe hemorrhage OR TI severe
obstetric haemorrhage OR AB severe obstetric haemorrhage OR TI severe obstetric hemorrhage OR AB severe obstetric
hemorrhage OR TI severe blood loss OR AB severe blood loss
Women’s emotional and physical
health problems
TI women’s health OR AB women’s health OR TI womens health OR AB womens health OR TI woman’s health
OR AB woman’s health OR TI womans health OR AB womans health OR TI health outcome OR AB health outcome
OR TI health outcomes OR AB health outcomes OR TI adverse outcome OR AB adverse outcome OR TI adverse
outcomes OR AB adverse outcomes OR TI pregnancy outcome OR AB pregnancy outcome OR TI pregnancy
outcomes OR AB pregnancy outcomes OR TI puerperal disorder OR AB puerperal disorder OR TI puerperal
disorders OR AB puerperal disorders OR TI maternal morbidity OR AB maternal morbidity OR TI maternal
morbidities OR AB maternal morbidities OR
TI mental health OR AB mental health OR TI mental disorder OR AB mental disorder OR TI mental disorders OR AB
mental disorders OR TI mental disease OR AB mental disease OR TI mental diseases OR AB mental diseases OR TI
emotional wellbeing OR AB emotional wellbeing OR TI emotional well being OR AB emotional well being OR TI
emotional well-being OR AB emotional well-being OR TI emotional health OR AB emotional health OR TI postnatal
depression OR AB postnatal depression OR TI post natal depression OR AB post natal depression OR TI post-natal
depression OR AB post-natal depression OR TI postpartum depression OR AB postpartum depression OR TI post
partum depression OR AB post partum depression OR TI post-partum depression OR AB post-partum depression
OR TI postnatal distress OR AB postnatal distress OR TI post natal distress OR AB post natal distress OR TI post-natal
distress OR AB post-natal distress OR TI postpartum distress OR AB postpartum distress OR TI post partum distress OR
AB post partum distress OR TI post-partum distress OR AB post-partum distress OR TI postnatal stress OR AB postnatal
stress OR TI post natal stress OR AB post natal stress OR TI post-natal stress OR AB post-natal stress OR TI perinatal
mental health OR AB perinatal mental health OR TI perinatal mental health problems OR AB perinatal mental health
problems OR TI peri natal mental health problems OR AB peri natal mental health problems Or TI perinatal mental
health problem OR AB perinatal mental health problem OR TI peri natal mental health problem OR AB peri natal
mental health problem OR TI postnatal anxiety OR AB postnatal anxiety OR TI post natal anxiety OR AB post natal
anxiety OR TI post-natal anxiety OR AB post-natal anxiety OR TI postpartum anxiety OR AB postpartum anxiety OR TI
post partum anxiety OR AB post partum anxiety OR TI post-partum anxiety OR AB post-partum anxiety OR OR TI
postnatal anxieties OR AB postnatal anxieties OR TI post natal anxieties OR AB post natal anxieties OR TI post-natal
anxieties OR AB post-natal anxieties OR TI postpartum anxieties OR AB postpartum anxieties OR TI post partum
anxieties OR AB post partum anxieties OR TI post-partum anxieties OR AB post-partum anxieties OR TI postnatal
psychosis OR AB postnatal psychosis OR TI post natal psychosis OR AB post natal psychosis OR TI post-natal psychosis
OR AB post-natal psychosis OR TI postpartum psychosis OR AB postpartum psychosis OR TI post partum psychosis OR
AB post partum psychosis OR TI post-partum psychosis OR AB post-partum psychosis OR
TI physical health OR AB physical health OR TI physical health problem OR AB physical health problem OR TI
physical health problems OR AB physical health problems OR TI health problem OR AB health problem OR TI
health problems OR AB health problems
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Characteristics of included studies
The characteristics of the included studies are illustrated
in Table 3. Five studies had the sequelae of PPH as their
primary focus. The remaining study [27] focused on
morbidity postnatally and we were able to extract data
on the population of women who experienced a PPH.
The majority of studies took place between 1995 and
2007, with one study conducted in 1989 (Table 3). Four
studies collected data over 1 to 3 years, and two studies
over a 5–9 year time-frame (Table 3).
Results of methodological quality assessment
All included studies were judged as having strong or
moderate methodological quality (Table 3). The two
studies judged as having only moderate methodological
quality were deemed so because PPH and/or the postna-
tal period were not defined in the publication.
Results of data extraction
The six included papers reported data from six individ-
ual studies conducted in seven countries. Five studies
were conducted in OECD countries and one in a non-
OECD country. Detailed characteristics of included pa-
pers are presented in Table 3. Five studies reported the
outcomes of primary PPH [25, 27, 28, 30, 31] and one
reported outcomes after secondary PPH [36].
Definitions of PPH
Studies varied in how they defined PPH, and these were
compared with the definitions provided by WHO [1],
RCOG [12], ICD-10 codes [13] and NICE [14]. One study,
which was reporting outcomes after severe or major
haemorrhage, stating it as ≥1,500mls, defined PPH in the
traditional manner, by amount of blood lost [27]. Two
studies [28, 30] used the ICD-9 codes to define PPH which
also includes “the amount that adversely affects the mater-
nal physiology, such as blood pressure and haematocrit”,
although these parameters are not defined. Three studies
defined PPH in a somewhat similar fashion, including
treatment required, e.g., “bleeding … persisting after man-
ual exploration of the uterine cavity and requiring I.V.
prostaglandin administration” [25], “findings of pelvic
examination, condition of the uterus” [31], “a fall in
Fig. 1 Flow diagram of the search and selection process
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Table 3 Characteristics and quality assessment of included studies
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bleeding
n = 32,463, Primigravida
women (women in their
first intended pregnancy)
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Yes 1995–2004 R, C ICD-9 √ n = 25,654, Primiparous
and Multiparous women
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MR (national
data)
HP at <1 Moderate
Liu et al.
(2002) [30]
Canada Yes 1989–99 R, C ICD-9 √ n = 2,652,726, Primiparous
and Multiparous women




HP at ≥1 < 3 Strong
Naz et al.
(2008) [31]
Pakistan No 2006 P, C Not stated Severity of bleeding
but not amount or
timing
n = 705, Primiparous and
Multiparous women who
had a Primary PPH
MR HP at <1 Moderate
Hoveyda and
MacKenzie (2001) [36]
England Yes 1996–98 R Similar Severity and timing
of bleeding but not
amount
n = 19,136, Primiparous
and Multiparous women
with Primary PPH, and those
with Secondary PPH
MR HP at <1 Strong













haemoglobin, for example, to 7 g/dl and/or by 4 g/dl or
more” [25, 27].
Outcomes of PPH
One study reported on outcomes post secondary PPH,
providing a definition similar to the RCOG’s (2014) [36].
In total, 44 outcomes were reported in the six included
papers (see Tables 4, 5 and 6 for a list and timeline of
the health outcomes). The number of reported health
problems varied from one (the rate of re-admission at
≥1 but <3 months postpartum [30]), to 31 [27]. Four
studies reported health outcomes in the 1st postpartum
month [25, 28, 31, 36], two at ≥1 < 3 [27, 30], and one at
≥3 < 6 [27]. Five reported outcomes following primary
PPH [25, 27, 28, 30, 31] and one following both primary
and secondary PPH [36].
The health outcomes reported in the early postpartum
period tended to be acute, i.e., renal failure, respiratory
failure, prolonged ventilation, coagulopathy/Dissemi-
nated Intravascular Coagulation (DIC), sepsis, anaemia,
Superficial Venous Thrombosis and perforation of the
uterus. Health problems reported in later months tended
to be less severe, and some had become chronic.
Thompson et al. [27] was the only study that reported
the prevalence of both emotional and physical health
problems following a significant (>1,500mls) primary
PPH between one and six months postpartum (Tables 5
and 6). The emotional health problems reported were
anxiety, postnatal depression, fatigue, post-traumatic
stress disorder and general health status, measured using
Speilberger State-Trait Anxiety Inventory, Edinburgh
Postnatal Depression Scale, Milligan’s 10-item Scale for
fatigue, 17-item PTSD Checklist and 360 item short
form General Health Survey. The physical problems re-
ported were infection (perineal, caesarean section (CS)
wound, uterine, breast), pain (perineal, site of CS scar),
urinary tract infection, incontinence (stress urinary, fae-
ces, flatus), constipation, backache, headaches (frequent)
and physical exhaustion. Women rated these as ‘not a
problem’, ‘a minor problem’, or ‘a major problem’.
Only two studies compared women who had primary
PPH with those who did not. Chauleur et al. [25] found
that women who experienced PPH were at increased risk
of superficial venous thrombosis (adjusted relative risk:
5.3, 95 % CI 1.6 to 17). Hoveyda & MacKenzie [36] ana-
lysed data from 657 women with primary PPH and found
33 (5.02 %) had a secondary PPH compared with only 99
out of 18,479 women who did not have primary PPH
(0.54 %), giving an odds ratio of 9.3 (95 % CI 6–2 to 14).
One other study [27] provided data on those women
re-admitted to hospital following a PPH at ≥ 1 month
and < 3 months postpartum (4108 out of 113,861, 3.61 %).
We compared these results with their data on the cohort
of women who did not have PPH and were re-admitted
(30,229 out of 2,538,865, 1.19 %). The difference was sta-
tistically significant with an odds ratio of 3.1 (95 % CI 3.01
to 3.21), p < 0.0001.
Data on sub-groups of women, grouped by parity, age
and BMI, following postpartum haemorrhage were not
reported in any paper. Due to the different types of
health outcomes reported in the individual studies, it
was possible to pool results from only four studies, and
only then by accepting the slightly differing definitions
of PPH. Combining the results of Bateman et al. [28]
Table 4 Reported health problems up to one month postpartum










Number of participants n = 317 n = 25,654 n = 50 n = 657 (primary PPH) n = 132 (secondary PPH)
Reported Health Problems up to 1 month postpartum
Acute Renal Failure 82 (0.32 %) 2 (4 %)
Acute Respiratory Failure 105 (0.41 %)
Anaemia 20 (40 %)
Anaemia + DIC 5 (10 %)
Anaemia + DIC + ARF 1 (2 %)
Coagulopathy / DIC 445 (1.73 %) 1 (2 %)
Length of stay more than 7 days 656 (2.56 %)
Perforation of the uterus 3 (2.27 %)
Prolonged mechanical ventilation (>96 h) 13 (0.05 %)
Secondary PPH 33 (5.02 %)
Sepsis / Infection 25 (0.1 %)
Shock + Anaemia 2 (4 %)
Superficial venous thrombosis 3 (0.9 %)a
aPrimiparous women only
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and Naz et al. [31] gave a total of 25,704 women. Acute
renal failure occurred in 84 women (0.33 %) and co-
agulopathy in 446 (1.74 %). However, it should be noted
that the study by Naz et al. [31] was conducted on 50
women who had primary PPH, of whom 10 (20 %) had a
subtotal hysterectomy performed, a population rate of
peripartum hysterectomy (1.42 %) far in excess of the
prevalence found in other countries. It is likely that the
high incidence of acute renal failure and other
complications seen in this study are due to the surgical
procedure, rather than PPH per se. The benefit of com-
bining these results is that a more realistic overall preva-
lence is reached.
The combined results of Liu et al. [30] and Thompson
et al. [27] in relation to those re-admitted to hospital fol-
lowing a PPH at ≥ 1 month and < 3 months postpartum,
gave a total of 4125 re-admissions out of 114,032
(3.6 %).
Discussion
There are few papers that report on health outcomes fol-
lowing a postpartum haemorrhage, despite the reported
increase in the incidence of PPH and more severe PPH,
across the globe [8–10]. Many papers focus only on the
risks for, and prevention of, maternal mortality due to
PPH, with scant regard for surviving women’s physical
Table 5 Reported health problems ≥ 1 month and < 3 months
postpartum




Number of participants n = 171 n = 113,861
Reported Health problems ≥ 1 < 3 months postpartum




Depression Scale > 12
19 (11 %)
Post-traumatic stress disorder: PCL > 44 9 (5 %)
Health Status: SF36 ‘somewhat worse
than 1 year ago’ ago’
46 (26.9 %)




i. Painful perineum (vaginal births only) 54/103 (52.5 %)
ii. Perineal infection (vaginal births only) 6/104 (5.8 %)
iii. Pain at CS site (CS births only) 53/65 (81.5 %)
iv. CS wound infection (CS births only) 12/65 (18.5 %)
v. Uterine infection 10 (5.9 %)
vi. Urinary tract infection 11 (6.5 %)
vii. Stress urinary incontinence 57 (33.5 %)
viii. Constipation 81 (47.6 %)
ix. Incontinence of faeces 10 (5.9 %)
x. Incontinence of flatus 31 (18.5 %)
xi. Breast infection/ mastitis 37 (21.8 %)
xii. Backache 92 (54.7 %)
xiii. Headache (frequent) 49 (29.2 %)
xiv. Physical exhaustion 119 (71.2 %)
Re-admission
Reasons:
17 (10 %) 4108 (3.6 %)
i. Mastitis/Breast abscess 4/17
ii. Bleeding/Retained of products
of conception
3/17
iii. Low haemoglobin/transfusion 3/17
iv. Problems with perineal stitches 2/17
v. Postnatal depression,
hyperventilation, pleuritic pain,




Table 6 Reported health problems ≥ 3 month and < 6 months
postpartum
References Thompson et al.
(2011) [27]
Number of participants n = 171
Anxiety: State Trait Anxiety Inventory (median) 10
Depression: Edinburgh Postnatal Depression Scale > 12 21 (13 %)
Post-traumatic stress disorder: PCL > 44 5 (3 %)
Health Status: SF36 ‘somewhat worse than 1 year ago’ 51 (30.7 %)
Health Status: SF36 ‘much worse than 1 year ago’ 10 (6 %)
Physical problems:
i. Painful perineum (vaginal births only) 25/100 (25 %)
ii. Perineal infection (vaginal births only) 0
iii. Pain at CS site (CS births only) 29/60 (48.3 %)
iv. CS wound infection (CS births only) 5/61 (8.2 %)
v. Uterine infection 4 (2.4 %)
vi. Urinary tract infection 6 (3.7 %)
vii. Stress urinary incontinence 42 (25.6 %)
viii. Constipation 39 (24 %)
ix. Incontinence of faeces 5 (3 %)
x. Incontinence of flatus 26 (16.1 %)
xi. Breast infection/ mastitis 22 (13.6 %)
xii. Backache 99 (60 %)
xiii. Headache (frequent) 51 (30.9 %)




i. Bleeding/ Retained of products of conception 2/4
ii. Post-natal depression 1/4
iii. Cholecystitis 1/4
CS caesarean section
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and emotional state. Women’s health and level of pos-
sible morbidity post PPH is thus virtually unknown.
From the 2210 papers identified in this review, only
six reported on outcomes following PPH. Of these, we
were unable to pool and meta-analyse most data because
of differing definitions of PPH, differing timing of meas-
urement or differing outcomes measured. Those that
could be pooled demonstrated a 0.33 % rate of acute
renal failure and a 1.74 % rate of coagulopathy. The re-
admission rate to hospital following a PPH between 1
and 3 months postpartum was 3.6 %, an appreciable in-
dication of underlying physical problems. Single studies
included in this review showed other types of morbidity
to be common; for example, depression (13 %) and a
health status at 6 months postpartum, as measured by
SF36, as ‘much worse than 1 year ago’ (6 %) [27].
Few studies of emotional sequelae of PPH within the
six month postpartum period were found. Some work
has shown that 68 % of 68 women surviving severe PPH
had negative memories of the event (such as fear of
dying (35 %)) when interviewed 4 to 17 years later) [5].
Sixty percent of the 15 women who went on to have
another pregnancy suffered severe anxiety throughout,
indicating the tenacity of such feelings. If emotional
morbidity from PPH could be detected in the early post-
partum months, and treated, it is possible that such
long-term psychological disability could be averted. The
first step, however, is to measure the prevalence and se-
verity of such morbidity and an observational study is in
progress in France that may provide more information
in this area [37].
Secondary PPH is poorly defined, yet it seems illogical
to define it as a blood loss of 500 mls, the amount used
to define primary PPH, because this is considered to be
in excess of what is considered a physiologically normal
blood loss during the third stage of labour. We suggest
that the definition should more correctly be: “any blood
loss from the gentital tract in excess of normal lochia at
any time period after 24 h post birth to 6 weeks
postpartum.”
It is clear that more research is needed, to ascertain the
amount and degree of both physical and emotional post-
partum morbidity following PPH. Before that, though, it is
important to develop a core outcomes set [38] for measur-
ing maternal health outcomes postpartum, perhaps as a
subset of the maternity core outcome set developed by
Devane et al. [39].
Strengths and limitations of this review
The findings from this review are based on a compre-
hensive systematic literature search of seven electronic
databases, and rigorous critical appraisal of included
studies. Two studies with large sample sizes [28, 30] in-
fluenced the overall results. Unfortunately there was
high heterogeneity between all studies, which is a major
limitation. We tried to be as inclusive as possible, but
we were unable to pool and meta-analyse most of the
findings, thus limiting the review’s potential to add new
knowledge to clinical practice. Despite this limitation,
the findings demonstrate that the prevalence of physical
and emotional health problems experienced by women
post PPH remain largely unknown, indicating the need
for further research in this area.
Conclusion
This review demonstrates that there are few studies exam-
ining the prevalence of maternal physical and health prob-
lems post PPH, and those that were found tended to be
either small and/or focussed on a limited number of mor-
bidities. PPH, estimated to affect as many as 8–11 million
women annually, is likely to impact negatively on women’s
health, and it is conceivable that existing health problems
experienced may be exacerbated. As these health prob-
lems remain virtually unknown, however, many women
may be suffering sequelae from PPH during the postpar-
tum period in the community, without proper diagnosis
or treatment. Further research is required, but because of
the variations in definitions used, and outcomes reported,
studies will require a clear definition of PPH, and valid
and reliable measuring instruments, based on a core out-
come set, to ascertain the timing, prevalence and severity
of health problems.
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